Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Zuricab 0.5mg Tablet
Manufacturer/Marketed By : ALKEM LABORATORIES LTD
$1.46 $1.17
Zuricab 0.5mg Tablet is a medication containing Cabergoline, which is primarily used to treat conditions associated with excess production of prolactin, a hormone produced by the pituitary gland. Prolactinomas (benign...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
CABERGOLINE
Active Pharmaceutical Ingredient
Zuricab 0.5mg Tablet
1,46$
1,17$
Zuricab 0.5mg Tablet is a medication containing Cabergoline, which is primarily used to treat conditions associated with excess production of prolactin, a hormone produced by the pituitary gland. Prolactinomas (benign tumors of the pituitary gland) are the most common cause of excessive prolactin levels, leading to symptoms like infertility, irregular menstrual cycles, and unwanted breast milk production (galactorrhea). Cabergoline helps reduce prolactin secretion by stimulating dopamine receptors in the brain, thereby correcting these hormone imbalances. This medication is also used in treating Parkinson’s disease in some cases, as it aids in balancing the neurotransmitters in the brain, improving movement and reducing stiffness. Zuricab 0.5mg Tablet works by directly targeting the root cause of prolactin-related disorders, offering relief from the symptoms caused by elevated prolactin levels.
Active Pharmaceutical Ingredient
Uses
• Hyperprolactinemia: Treats elevated prolactin levels caused by prolactinomas or other conditions affecting the pituitary gland.
• Parkinson’s Disease: Sometimes used to treat Parkinson’s disease as a dopamine agonist to improve motor function.
Benefits
Cabergoline in Zuricab 0.5mg Tablet effectively lowers prolactin levels in the blood by mimicking the effects of dopamine in the brain. This helps restore normal hormonal balance, alleviating symptoms such as galactorrhea, amenorrhea, and infertility. For patients with Parkinson’s disease, Zuricab can improve movement control and reduce stiffness by stimulating dopamine receptors in the brain. Regular use of the tablet significantly reduces the impact of prolactin-related conditions and helps prevent complications such as infertility and menstrual irregularities.
Side Effects
Common side effects of Zuricab 0.5mg Tablet may include:
Most Common Side Effects
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Common Side Effects
• Nausea
• Headache
• Dizziness
• Fatigue
• Abdominal pain
How To Use
Take Zuricab 0.5mg Tablet orally with a glass of water, typically once or twice a week, depending on your doctor’s instructions. The tablet can be taken with or without food. Your doctor will adjust the dosage based on your response and prolactin levels, and it’s essential to follow the prescribed schedule to ensure optimal results. Do not break, chew, or crush the tablet.
Safety Advice
• Breast Feeding: Can suppress milk production, so it is not recommended for breastfeeding mothers.
• Alcohol: It is advisable to limit alcohol consumption while taking Zuricab 0.5mg Tablet as alcohol can increase the risk of dizziness and drowsiness.
• Liver: Liver-related side effects are rare but may include elevated liver enzymes. If you experience symptoms such as yellowing of the skin, dark urine, or persistent abdominal pain, consult your healthcare provider.
• Lungs: While lung-related issues are not common with Zuricab 0.5mg Tablet, some individuals may experience pleural effusion (fluid buildup in the lungs) and pulmonary fibrosis (lung tissue scarring) as rare side effects.
• Driving: Avoid driving or doing heavy mechanical work if you feel dizzy post taking the medicine.
• Pregnancy: Zuricab 0.5mg Tablet should be used during pregnancy only if clearly necessary. Consult your doctor if you are pregnant or planning to conceive.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.